Literature DB >> 16618731

Id1 transcription inhibitor-matrix metalloproteinase 9 axis enhances invasiveness of the breakpoint cluster region/abelson tyrosine kinase-transformed leukemia cells.

Margaret Nieborowska-Skorska1, Grazyna Hoser, Lori Rink, Maciej Malecki, Plamen Kossev, Mariusz A Wasik, Tomasz Skorski.   

Abstract

Breakpoint cluster region/Abelson (BCR/ABL) tyrosine kinase enhances the ability of leukemia cells to infiltrate various organs. We show here that expression of the helix-loop-helix transcription factor Id1 is enhanced by BCR/ABL in a signal transducer and activator of transcription 5 (STAT5)-dependent manner. Enhanced expression of Id1 plays a key role in BCR/ABL-mediated cell invasion. Down-regulation of Id1 in BCR/ABL leukemia cells by the antisense cDNA significantly reduced their invasive capability through the Matrigel membrane and their ability to infiltrate hematopoietic and nonhematopoietic organs resulting in delayed leukemogenesis in mice. The Id1-promoted cell invasiveness was seemingly mediated by matrix metalloproteinase 9 (MMP9). Transactivation of MMP9 promoter in BCR/ABL cells was dependent on Id1 and abrogation of the MMP9 catalytic activity by a metalloproteinase inhibitor or blocking antibody decreased invasive capacity of leukemia cells. These data suggest that BCR/ABL-STAT5-Id1-MMP9 pathway may play a critical role in BCR/ABL-mediated leukemogenesis by enhancing invasiveness of leukemia cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16618731     DOI: 10.1158/0008-5472.CAN-05-1584

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

1.  Smad signaling in the neural crest regulates cardiac outflow tract remodeling through cell autonomous and non-cell autonomous effects.

Authors:  Qunshan Jia; Bradley W McDill; Song-Zhe Li; Chuxia Deng; Ching-Pin Chang; Feng Chen
Journal:  Dev Biol       Date:  2007-08-31       Impact factor: 3.582

Review 2.  The ID proteins: master regulators of cancer stem cells and tumour aggressiveness.

Authors:  Anna Lasorella; Robert Benezra; Antonio Iavarone
Journal:  Nat Rev Cancer       Date:  2014-01-20       Impact factor: 60.716

3.  Enhanced phosphorylation of Nbs1, a member of DNA repair/checkpoint complex Mre11-RAD50-Nbs1, can be targeted to increase the efficacy of imatinib mesylate against BCR/ABL-positive leukemia cells.

Authors:  Lori Rink; Artur Slupianek; Tomasz Stoklosa; Margaret Nieborowska-Skorska; Katarzyna Urbanska; Ilona Seferynska; Krzysztof Reiss; Tomasz Skorski
Journal:  Blood       Date:  2007-04-12       Impact factor: 22.113

4.  Lipocalin 2 is required for BCR-ABL-induced tumorigenesis.

Authors:  X Leng; H Lin; T Ding; Y Wang; Y Wu; S Klumpp; T Sun; Y Zhou; P Monaco; J Belmont; A Aderem; S Akira; R Strong; R Arlinghaus
Journal:  Oncogene       Date:  2008-07-28       Impact factor: 9.867

5.  Abl interactor 1 regulates Src-Id1-matrix metalloproteinase 9 axis and is required for invadopodia formation, extracellular matrix degradation and tumor growth of human breast cancer cells.

Authors:  Xiaolin Sun; Chenghai Li; Chunmei Zhuang; William C Gilmore; Everardo Cobos; Yunxia Tao; Zonghan Dai
Journal:  Carcinogenesis       Date:  2009-12       Impact factor: 4.944

6.  Role of leukemia cell invadosome in extramedullary infiltration.

Authors:  Michael Stefanidakis; Katja Karjalainen; Diana E Jaalouk; Carl G Gahmberg; Susan O'Brien; Renata Pasqualini; Wadih Arap; Erkki Koivunen
Journal:  Blood       Date:  2009-07-27       Impact factor: 22.113

Review 7.  ID proteins regulate diverse aspects of cancer progression and provide novel therapeutic opportunities.

Authors:  Radhika Nair; Wee Siang Teo; Vivek Mittal; Alexander Swarbrick
Journal:  Mol Ther       Date:  2014-05-14       Impact factor: 11.454

8.  Small-molecule inhibitors of USP1 target ID1 degradation in leukemic cells.

Authors:  Helena Mistry; Grace Hsieh; Sara J Buhrlage; Min Huang; Eunmi Park; Gregory D Cuny; Ilene Galinsky; Richard M Stone; Nathanael S Gray; Alan D D'Andrea; Kalindi Parmar
Journal:  Mol Cancer Ther       Date:  2013-10-15       Impact factor: 6.261

9.  Do stress responses promote leukemia progression? An animal study suggesting a role for epinephrine and prostaglandin-E2 through reduced NK activity.

Authors:  Shelly Inbar; Elad Neeman; Roi Avraham; Marganit Benish; Ella Rosenne; Shamgar Ben-Eliyahu
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

10.  The effect of a DNA repair gene on cellular invasiveness: XRCC3 over-expression in breast cancer cells.

Authors:  Veronica L Martinez-Marignac; Amélie Rodrigue; David Davidson; Martin Couillard; Ala-Eddin Al-Moustafa; Mark Abramovitz; William D Foulkes; Jean-Yves Masson; Raquel Aloyz
Journal:  PLoS One       Date:  2011-01-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.